Pulmonary Vasodilators Flashcards
Classify the pulmonary vasodilators
INHALED
- Nitric Oxide
- Prostaglandin I2 (Epoprostenol)
- Oxygen
NON-INHALED
- Sildenafil
- Tadalafil
- Milrinone
How is Nitric Oxide administered for the treatment of pulmonary hypertension
INOMax - proprietary system
Administered as part of an inspired gas admixture
Fraction measured in tens of ppm
How is Epoprostenol (PGI2) administered for the treatment of pulmonary hypertension
Can be intravenous but usually nebulized as part of a solution with a glycine buffer using a continuous ultrasonic nebulizer
Why does Epoprostenol require glycine buufer
Requires glycine buffer and sodium hydroxide because its pKa is 4.4 and spontaneous hydrolysis of the drug occurs in aqueous solution at normal pH
The reconstituted mixture has a pH of 12
What is the mechanism of action of Nitric Oxide
Increased Nitric oxide –> Activation guanylate cyclase –> increase cGMP –> smooth muscle relaxation
How is endogenous secretion of nitric oxide initiated
Acetylcholine (PSNS) binds M3 receptors on endothelial cell membrane –> Gq coupled –> IP3 –> Ca induced Ca release from SR –> Ca-Calmodulin –> NO production.
List the Muscarinic receptors
- name each of their 2nd messenger systems and functions
M1 - Gq (IP3) —> Cognitive/memory/seizures
M2 - Gi (- AC) —> Mainly cardiac and eyes
M3 - Gq (IP3) —> Mainly Lungs, GIT, eyes, urogenital
M4 - Gi (- AC) —> Inhibits ntmtr release CNS / Dopamine
M5 - Gq (IP3) —> facilitates dopamine release
What are the routes of administration of oxygen
- Inhaled
- IV (ECMO)
- External (hyperbaric oxygen therapy)
What is the mechanism of action of oxygen
Increases ATP by acting as a substrate for aerobic metabolism of glucose
How does O2 cause vasodilatation of the pulmonary vasculature
It prevents vasoconstriction of the pulmonary vasculature by averting hypoxic pulmonary vasoconstriction
List the Oral and IV drugs used for pulmonary vasodilatation
Oral
- Sildenafil
IV
- milrinone
Differentiate the mechanisms of action of milrinone vs sildenafil
Sildenafil - PDE 5 inhibitor
–> Increase cGMP in vascular smooth muscle –> pulmonary vasodilation
Milrinone - PDE 3 inhibitor
–> Increase cAMP in vascular smooth muscle –> inhibition of MLCK –> relaxation vascular smooth muscle –> pulmonary vasodilatation
Compare the metabolism of milrinone and sildenafil
Sildenafil –> CYP3A4 –> active metabolite with 50% activity of sildenafil
Milrinone –> Renal
Describe the clinical effects of sildenafil and milrinone
Pulmonary vasodilation Hypotension Reflex tachycardia Headache Priapism
How does the function of milrinone differ from sildenafil
Milrinone
–> Improves myocardial contractility
Propensity for arrhythmias